Business Segments Alfresa Holdings Corporation

Stocks

Delayed Japan Exchange 09:09:40 24/09/2026 +04			5-day change	1st Jan Change
2,378.50 ^JPY	+1.08%		-0.21%	-2.20%

07-01	Ember LifeSciences, Inc. announced that it has received funding from Alfresa Holdings Corporation	CI
06-22	Alfresa Holdings Corporation(TSE:2784) dropped from S&P Japan Mid Cap 100	CI

Breakdown by Business Segment (JPY)

Fiscal Period: March	2022	2023	2024	2025	2026
Pharmaceutical Product Distribution
Pharmaceutical Products Wholesale Segment	2,288B	2,395B	2,540B	2,640B	2,783B
Total Assets	1,118B	1,139B	1,240B	1,238B	1,311B
CAPEX	-9.58B	-8.53B	-	-14.03B	-12.57B
D&A	6B	6.16B	6.2B	7.66B	7.67B
Operating Income	24.84B	26.97B	33.09B	33.06B	33.3B
	-	-	-	-	448M
Self-Medication Wholesale Business	245B	247B	263B	266B	267B
Total Assets	83B	89.72B	93.97B	93.03B	91.87B
CAPEX	-306M	-251M	-	-948M	-233M
D&A	357M	326M	364M	346M	384M
Operating Income	1.87B	2.11B	2.68B	2.95B	3.01B
	-	-	-	-	19.5B
Pharmaceutical Contract Manufacturing Services
Pharmaceutical Manufacturing Business	47.36B	49.04B	52.74B	54.06B	52.18B
Total Assets	70.53B	70.08B	67.37B	73.01B	80.13B
CAPEX	-3.94B	-1.96B	-	-3.08B	-20.34B
D&A	3.55B	3.84B	3.85B	3.78B	3.22B
Operating Income	1.87B	420M	1.89B	1.29B	1.2B
	-	-	-	-	15B
Drug Stores and Pharmacies
Dispensing Pharmacy Business	34.47B	36.2B	36.65B	37.02B	37.17B
Total Assets	16.72B	16.33B	16.8B	16.5B	17.04B
CAPEX	-426M	-912M	-	-741M	-405M
D&A	777M	658M	613M	639M	434M
Operating Income	183M	330M	713M	596M	499M
	-	-	-	-	0
Unallocated Adjustment	-29.11B	-31.21B	-33.67B	-35.83B	-34.95B
Total Assets	-	-	-	-	-
CAPEX	-2.09B	-2.02B	-	-2.65B	-7.4B
D&A	2.14B	2.31B	2.49B	2.49B	2.82B
Operating Income	-	-	-	-	-
Operating Income	224M	134M	-89M	200M	-960M
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
Total Assets	27.06B	36.04B	41.1B	30.89B	17.61B
Total Assets	-11.61B	-11.35B	-11.7B	-11.63B	-12.82B
Operating Income	108M	181M	168M	-17M	211M
D&A	-	-	-	-	-
Total Assets	-	-	-	-	2.03B
CAPEX	-	-	-	-	-55M
D&A	-	-	-	-	104M
Operating Income	-	-	-	-	-1.1B
Operating Income	-	-	-	-	-

Geographical breakdown of sales (JPY)

Fiscal Period: March	2022	2023	2024	2025	2026
Japan	2,586B	2,696B	2,858B	2,961B	3,104B
Total Assets	1,304B	1,340B	1,448B	1,440B	1,507B
Interest Expense	-73M	-64M	-132M	-279M	-354M
Income Tax Expense	15.98B	12.8B	14.22B	11.92B	20.18B
D&A	12.82B	13.3B	13.51B	14.92B	15.05B
CAPEX	-16.99B	-25.46B	-12.74B	-16.51B	-22.46B
Gross Profit	187B	192B	206B	214B	218B
Net Income	32.18B	25.79B	29.56B	27.39B	41.75B
EBT	48.18B	38.59B	43.8B	39.36B	62.01B
Operating Income	29.09B	30.15B	38.46B	38.08B	36.16B